To investigate which metabolic pathways are associated with the prognosis of GBM, we have analyzed the expression profile of metabolic-related genes of the 149 GBM patients (all lacking IDH1 mutation) based on their transcriptomic data (see Section 2). The gene discussed is IDH1; the disease is glioblastoma.